Bioequivalence and safety evaluation of two preparations of metformin hydrochloride sustained-release tablets (Boke(®) and Glucophage(®)-XR) in healthy Chinese volunteers: a randomized phase I clinical trial

BACKGROUND: As per the National Medical Products Administration (NMPA) requirements, the quality and efficacy of generic drugs must be consistent with those of the innovator drug. We aimed to evaluate the bioequivalence and safety of generic metformin hydrochloride sustained-release (MH-SR) tablets...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Ming-Li, Liu, Chen, Bai, Hai-Hong, Wei, Ya-Li, Zhang, Wei, Liu, Hui-Juan, Li, Yin-Juan, Liu, Long, Wang, Yu, Tong, Yuan-Xv, Gao, Qian, Liu, Qian-Ying, Wang, Xinghe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9521607/
https://www.ncbi.nlm.nih.gov/pubmed/36135935
http://dx.doi.org/10.1080/07853890.2022.2125574

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9521607/
https://www.ncbi.nlm.nih.gov/pubmed/36135935
http://dx.doi.org/10.1080/07853890.2022.2125574

Ejemplares similares